Encompass Health Corporation Interest Expense
Encompass Health Corporation (EHC) reported Interest Expense of $35.20 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-02
- Encompass Health Corporation interest expense for the quarter ending 2024-03-31 was $35.20M, a 3.30% decline year-over-year.
- Encompass Health Corporation interest expense for the quarter ending 2023-12-31 was $34.90M, a 6.93% decline year-over-year.
- Encompass Health Corporation interest expense for the quarter ending 2023-09-30 was $35.90M, a 6.02% decline year-over-year.
- Encompass Health Corporation interest expense for the quarter ending 2023-06-30 was $36.30M, a 39.90% decline year-over-year.
- Encompass Health Corporation interest expense for fiscal 2023 was $143.50M, a 18.33% decline from fiscal 2022.
- Encompass Health Corporation interest expense for fiscal 2022 was $175.70M, a 6.94% increase from fiscal 2021.
- Encompass Health Corporation interest expense for fiscal 2021 was $164.30M, a 10.56% decline from fiscal 2020.
- Encompass Health Corporation interest expense for fiscal 2020 was $183.70M, a 15.03% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $35.20M 10-Q · filed 2024-05-02 | $70.10M derived: sum of 2 quarters · filed 2024-05-02 | $106.00M derived: sum of 3 quarters · filed 2024-05-02 | $142.30M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-12-31 | $34.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $70.80M derived: sum of 2 quarters · filed 2024-02-28 | $107.10M derived: sum of 3 quarters · filed 2024-02-28 | $143.50M 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $35.90M 10-Q · filed 2023-11-01 | $72.20M derived: sum of 2 quarters · filed 2023-11-01 | $108.60M 10-Q · filed 2023-11-01 | $146.10M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-06-30 | $36.30M 10-Q · filed 2023-08-04 | $72.70M 10-Q · filed 2023-08-04 | $110.20M derived: sum of 3 quarters · filed 2024-05-02 | $148.40M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-03-31 | $36.40M 10-Q · filed 2024-05-02 | $73.90M derived: sum of 2 quarters · filed 2024-05-02 | $112.10M derived: sum of 3 quarters · filed 2024-05-02 | $172.50M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $37.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $75.70M derived: sum of 2 quarters · filed 2024-02-28 | $136.10M derived: sum of 3 quarters · filed 2024-02-28 | $175.70M 10-K · filed 2024-02-28 | ||||
| 2022-09-30 | $38.20M 10-Q · filed 2023-11-01 | $98.60M derived: sum of 2 quarters · filed 2023-11-01 | $138.20M 10-Q · filed 2023-11-01 | $178.20M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $60.40M 10-Q · filed 2023-08-04 | $60.60M 10-Q · filed 2022-08-04 | $100.00M 10-Q · filed 2023-08-04 | $100.20M 10-Q · filed 2022-08-04 | $140.00M derived: sum of 3 quarters · filed 2024-02-28 | $179.90M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $39.60M 10-Q · filed 2023-05-03 | $79.60M derived: sum of 2 quarters · filed 2024-02-28 | $119.50M derived: sum of 3 quarters · filed 2024-02-28 | $161.30M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $79.90M derived: sum of 2 quarters · filed 2024-02-28 | $121.70M derived: sum of 3 quarters · filed 2024-02-28 | $164.30M 10-K · filed 2024-02-28 | $164.60M 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $39.90M 10-Q · filed 2022-11-02 | $81.70M derived: sum of 2 quarters · filed 2022-11-02 | $124.30M 10-Q · filed 2022-11-02 | $124.50M 10-Q · filed 2021-11-02 | $170.20M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $41.80M 10-Q · filed 2022-08-04 | $84.60M 10-Q · filed 2022-08-04 | $130.30M derived: sum of 3 quarters · filed 2023-02-27 | $179.30M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $42.80M 10-Q · filed 2022-05-03 | $88.50M derived: sum of 2 quarters · filed 2023-02-27 | $137.50M derived: sum of 3 quarters · filed 2023-02-27 | $183.30M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $45.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $94.70M derived: sum of 2 quarters · filed 2023-02-27 | $140.50M derived: sum of 3 quarters · filed 2023-02-27 | $183.70M 10-K · filed 2023-02-27 | $184.20M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $49.00M 10-Q · filed 2021-11-02 | $94.80M derived: sum of 2 quarters · filed 2021-11-02 | $138.00M 10-Q · filed 2021-11-02 | $182.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $45.80M 10-Q · filed 2021-08-03 | $89.00M 10-Q · filed 2021-08-03 | $133.50M derived: sum of 3 quarters · filed 2022-02-25 | $173.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $43.20M 10-Q · filed 2021-05-04 | $87.70M derived: sum of 2 quarters · filed 2022-02-25 | $128.00M derived: sum of 3 quarters · filed 2022-02-25 | $165.70M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $44.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $84.80M derived: sum of 2 quarters · filed 2022-02-25 | $122.50M derived: sum of 3 quarters · filed 2022-02-25 | $159.70M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $40.30M 10-Q · filed 2020-11-02 | $78.00M derived: sum of 2 quarters · filed 2020-11-02 | $115.20M 10-Q · filed 2020-11-02 | $151.90M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $37.70M 10-Q · filed 2020-07-31 | $74.90M 10-Q · filed 2020-07-31 | $111.60M derived: sum of 3 quarters · filed 2021-02-26 | $148.90M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $37.20M 10-Q · filed 2020-05-11 | $73.90M derived: sum of 2 quarters · filed 2021-02-26 | $111.20M derived: sum of 3 quarters · filed 2021-02-26 | $148.90M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $74.00M derived: sum of 2 quarters · filed 2021-02-26 | $111.70M derived: sum of 3 quarters · filed 2021-02-26 | $147.30M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $37.30M 10-Q · filed 2019-10-31 | $75.00M derived: sum of 2 quarters · filed 2019-10-31 | $110.60M 10-Q · filed 2019-10-31 | $146.50M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $37.70M 10-Q · filed 2019-07-31 | $73.30M 10-Q · filed 2019-07-31 | $109.20M derived: sum of 3 quarters · filed 2020-02-27 | $146.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $35.60M 10-Q · filed 2019-05-01 | $71.50M derived: sum of 2 quarters · filed 2020-02-27 | $108.30M derived: sum of 3 quarters · filed 2020-02-27 | $148.70M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $35.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $72.70M derived: sum of 2 quarters · filed 2020-02-27 | $113.10M derived: sum of 3 quarters · filed 2020-02-27 | $154.40M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $36.80M 10-Q · filed 2018-10-31 | $77.20M derived: sum of 2 quarters · filed 2018-10-31 | $118.50M 10-Q · filed 2018-10-31 | $160.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $40.40M 10-Q · filed 2018-08-02 | $81.70M 10-Q · filed 2018-08-02 | $123.30M derived: sum of 3 quarters · filed 2019-02-27 | $165.80M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $41.30M 10-Q · filed 2018-05-02 | $82.90M derived: sum of 2 quarters · filed 2019-02-27 | $125.40M derived: sum of 3 quarters · filed 2019-02-27 | $168.80M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $41.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $84.10M derived: sum of 2 quarters · filed 2019-02-27 | $127.50M derived: sum of 3 quarters · filed 2019-02-27 | $172.10M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $42.50M 10-Q · filed 2017-10-31 | $85.90M derived: sum of 2 quarters · filed 2017-10-31 | $130.50M 10-Q · filed 2017-10-31 | $175.10M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $43.40M 10-Q · filed 2017-08-02 | $88.00M 10-Q · filed 2017-08-02 | $132.60M derived: sum of 3 quarters · filed 2018-02-28 | $168.20M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $44.60M 10-Q · filed 2017-04-28 | $89.20M derived: sum of 2 quarters · filed 2018-02-28 | $124.80M derived: sum of 3 quarters · filed 2018-02-28 | |||||
| 2015-12-31 | $44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $80.20M derived: sum of 2 quarters · filed 2018-02-28 | $142.90M 10-K · filed 2018-02-28 | |||||
| 2015-09-30 | $35.60M 10-Q · filed 2016-10-28 | $98.30M 10-Q · filed 2016-10-28 | ||||||
| 2014-12-31 | $109.20M 8-K · filed 2017-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |